Chloe Comarmond
Impact in
- Infectious Diseases top 10%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
Papers in
-
- Vasculitis and related conditions 7
-
- COVID-19 Clinical Research Studies 3
- SARS-CoV-2 and COVID-19 Research 2
- Co-authors
- Mathieu Vautier (4 shared papers)Patrice Cacoub (4 shared papers)David Saadoun (4 shared papers)Matthieu Resche‐Rigon (2 shared papers)Yasmina Ferfar (2 shared papers)Anne Claire Desbois (3 shared papers)M. Lambert (1 shared paper)D. Sène (2 shared papers)
- Journals
- Lara D. Veeken (2 papers)Circulation (1 paper)EClinicalMedicine (1 paper)Neurology (1 paper)Orphanet Journal of Rare Diseases (1 paper)
- Partner nations
- FranceUnited StatesItaly
In The Last Decade
Chloe Comarmond
17 papers receiving 406 citations
Chloe Comarmond's Hit Papers
Peers
Comparison fields: 5 of 49
- Infectious Diseases 151
- Internal Medicine 15
- Neurology 59
- Rheumatology 46
- Pulmonary and Respiratory Medicine 76
Countries citing papers authored by Chloe Comarmond
This map shows the geographic impact of Chloe Comarmond's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chloe Comarmond with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chloe Comarmond more than expected).
Fields of papers citing papers by Chloe Comarmond
This network shows the impact of papers produced by Chloe Comarmond. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chloe Comarmond. The network helps show where Chloe Comarmond may publish in the future.
Co-authors
The 25 scholars most cited alongside Chloe Comarmond, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | COVID-19 outcomes in patients with inflammatory rheumatic and musculoskeletal diseases treated with rituximab: a cohort study Hit paper breakdown → | 2021 | 209 |
| 2 | 2023 | 56 | |
| 3 | 2021 | 24 | |
| 4 | 2020 | 19 | |
| 5 | 2020 | 18 | |
| 6 | 2021 | 17 | |
| 7 | 2023 | 16 | |
| 8 | 2021 | 13 | |
| 9 | 2024 | 12 | |
| 10 | 2022 | 8 | |
| 11 | 2021 | 5 | |
| 12 | 2023 | 4 | |
| 13 | 2024 | 4 | |
| 14 | 2023 | 3 | |
| 15 | 2024 | 2 | |
| 16 | 2020 | 1 | |
| 17 | 2025 | 1 | |
| 18 | 2026 | 0 | |
| 19 | 2025 | 0 |
About Chloe Comarmond
Chloe Comarmond is a scholar working on Pulmonary and Respiratory Medicine, Infectious Diseases, Physiology, Neurology and Internal Medicine, having authored 19 papers that have together received 412 indexed citations. Recurring topics across this work include Vasculitis and related conditions (7 papers), COVID-19 Clinical Research Studies (3 papers), SARS-CoV-2 and COVID-19 Research (2 papers), Sarcoidosis and Beryllium Toxicity Research (2 papers), Venous Thromboembolism Diagnosis and Management (1 paper), Antibiotics Pharmacokinetics and Efficacy (1 paper), Diabetes and associated disorders (1 paper) and Intracerebral and Subarachnoid Hemorrhage Research (1 paper). The work is most often cited by research in Infectious Diseases (151 citations), Internal Medicine (15 citations), Neurology (59 citations), Rheumatology (46 citations) and Pulmonary and Respiratory Medicine (76 citations). Chloe Comarmond has collaborated with scholars based in France, United States and Italy. Frequent co-authors include Mathieu Vautier, Patrice Cacoub, David Saadoun, Matthieu Resche‐Rigon, Yasmina Ferfar, Anne Claire Desbois, M. Lambert, D. Sène, Achille Aouba and Tristan Mirault. Their work appears in journals such as Lara D. Veeken, Circulation, EClinicalMedicine, Neurology and Orphanet Journal of Rare Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.